2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 2022 CDC Clinical Practice Guideline - Profiles
... 3 2022 CDC Clinical Practice Guideline - Terminology
... 4 2022 CDC Clinical Practice Guideline - Examples
... 5 2022 CDC Clinical Practice Guideline - Documentation
.... 5.1 2022 CDC Clinical Practice Guideline - Process Documentation
... 6 2022 CDC Clinical Practice Guideline - Downloads
... 7 2022 CDC Clinical Practice Guideline - User Interaction Alerts
... 8 2022 CDC Clinical Practice Guideline - Implementation Notes
... 9 2022 CDC Clinical Practice Guideline - Subroutines
... 10 2022 CDC Clinical Practice Guideline - Acute Pain
... 11 Chronic Pain Decision Documentation
... 12 Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration
... 13 Recommendation #2 - Prioritize Nonopioid Pain Therapies
... 14 Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy
... 15 Recommendations #4 and #5 - Lowest Effective Dose
... 16 Recommendation #6 - Prescribe Lowest Effective Dose and Duration
... 17 Recommendation #7 - Opioid Therapy Risk Assessment
... 18 Recommendation #8 - Naloxone Consideration
... 19 Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions
... 20 Recommendation #10 - Urine Drug Testing
... 21 Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines
... 22 Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder
... 23 License and Legal Terms
... 24 Artifacts Summary
.... 24.1 HelloWorld
.... 24.2 HelloWorldPatientView
.... 24.3 CDCMMEClinicalConversionFactors
.... 24.4 OpioidCDSRoutines
.... 24.5 OpioidCDSCommon
.... 24.6 OpioidCDSCommonConfig
.... 24.7 OpioidLogicMK2020
.... 24.8 OpioidData2020
.... 24.9 FHIRHelpers
.... 24.10 FHIRModelInfo
.... 24.11 OpioidCDSREC10CommonLibrary
.... 24.12 OpioidCDSREC01Library
.... 24.13 OpioidCDSREC02Library
.... 24.14 OpioidCDSREC03Library
.... 24.15 OpioidCDSREC04And05Library
.... 24.16 OpioidCDSREC06Library
.... 24.17 OpioidCDSREC07Library
.... 24.18 OpioidCDSREC08Library
.... 24.19 OpioidCDSREC09Library
.... 24.20 OpioidCDSREC10OrderSignLibrary
.... 24.21 OpioidCDSREC10PatientViewLibrary
.... 24.22 OpioidCDSREC11OrderSelectLibrary
.... 24.23 OpioidCDSREC11PatientViewLibrary
.... 24.24 OpioidCDSREC12PatientViewLibrary
.... 24.25 OpioidRiskAssessmentActivityDefinition
.... 24.26 OpioidUrineScreeningActivityDefinition
.... 24.27 OpioidUrineScreeningActivityDefinition
..... 24.27.1 Library
.... 24.28 OpioidUrineScreeningActivityDefinition
..... 24.28.1 Library
.... 24.29 Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration
..... 24.29.1 Library
.... 24.30 Recommendation #2 - Opioid Therapy Goals Discussion
..... 24.30.1 Library
.... 24.31 Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy
..... 24.31.1 Library
.... 24.32 Recommendations #4 and #5 - Lowest Effective Dose
..... 24.32.1 Library
.... 24.33 Recommendation #6 - Prescribe Lowest Effective Dose and Duration
..... 24.33.1 Library
.... 24.34 Recommendation #7 - Opioid Therapy Risk Assessment
..... 24.34.1 Library
.... 24.35 Recommendation #8 - Naloxone Consideration
..... 24.35.1 Library
.... 24.36 Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions
..... 24.36.1 Library
.... 24.37 Recommendation #10 - Urine Drug Testing (order-sign)
..... 24.37.1 Library
.... 24.38 Recommendation #10 - Urine Drug Testing (patient-view)
..... 24.38.1 Library
.... 24.39 Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines (order-select)
..... 24.39.1 Library
.... 24.40 Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines (patient-view)
..... 24.40.1 Library
.... 24.41 Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder (patient-view)
..... 24.41.1 Library
.... 24.42 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4
.... 24.43 Morphine Milligram Equivalent (MME) Calculator for FHIR R4
.... 24.44 Opioid Management Terminology Knowledge Data
.... 24.45 Opioid Management Terminology Knowledge Logic
.... 24.46 CDC_ValueSet
.... 24.47 DataDateRollerExtension
.... 24.48 CDC 2022 Opioid Guidance Clinical Focus Extension
.... 24.49 CDC 2022 Opioid Guidance Data Element Extension
.... 24.50 CDC 2022 Opioid Guidance exclusion Criteria Extension
.... 24.51 CDC 2022 Opioid Guidance Inclusion Criteria Extension
.... 24.52 All urine drug screening tests
.... 24.53 Amphetamine-class drugs and metabolite urine tests
.... 24.54 Amphetamine class medications
.... 24.55 Barbiturate Medications
.... 24.56 Barbiturate urine drug screening tests
.... 24.57 Benzodiazepine medications
.... 24.58 Benzodiazepine urine drug screening tests
.... 24.59 Buprenorphine and Methadone medications
.... 24.60 Buprenorphine Medications
.... 24.61 Buprenorphine urine drug screening tests
.... 24.62 Cannabinoid class urine drug screening
.... 24.63 CDC malignant cancer conditions
.... 24.64 CNS depressant medications
.... 24.65 Cocaine urine drug screening tests
.... 24.66 Sleep disordered breathing
.... 24.67 Conditions documenting substance misuse
.... 24.68 Conditions likely terminal for opioid prescribing
.... 24.69 Extended release opioid with ambulatory misuse potential
.... 24.70 Fentanyl-type medications
.... 24.71 Fentanyl-type urine drug screening tests
.... 24.72 General opiate urine drug screening tests
.... 24.73 Heroin urine drug screening tests
.... 24.74 Hospice Finding
.... 24.75 Hospice Procedure
.... 24.76 Limited life expectancy conditions
.... 24.77 Methadone medications
.... 24.78 Methadone urine drug screening tests
.... 24.79 Naloxone medications
.... 24.80 Non-opioid drug urine screening
.... 24.81 Non-synthetic opioid medications
.... 24.82 Oncology specialty designations (NUCC)
.... 24.83 Opiate specific urine drug screening tests
.... 24.84 Opioid analgesics with ambulatory misuse potential
.... 24.85 Opioid counseling procedure
.... 24.86 Opioid misuse assessment procedure
.... 24.87 Opioid misuse disorders
.... 24.88 Opioid treatment assessment procedure
.... 24.89 Opioid drug urine screening
.... 24.90 Oxycodone Medications
.... 24.91 Oxycodone urine drug screening tests
.... 24.92 Pain management procedure
.... 24.93 Pain treatment plan
.... 24.94 PDMP data reviewed finding
.... 24.95 PDMP review procedure
.... 24.96 Phencyclidine urine drug screening tests
.... 24.97 Sickle-cell diseases
.... 24.98 Substance misuse behavioral counseling
.... 24.99 Synthetic opioid medications
.... 24.100 Synthetic opioid urine drug screening tests
.... 24.101 Therapies indicating end of life care
.... 24.102 Condition Clinical Status Active
.... 24.103 Encounter Diagnosis Condition Category
.... 24.104 Problem List Condition Category
.... 24.105 US Core Health Concern Condition Category
.... 24.106 Hospice Disposition
.... 24.107 ValueSet - Medication Request Category Community
.... 24.108 ValueSet - Medication Request Status Active
.... 24.109 Observation Category Laboratory
.... 24.110 Observation Category Procedure
.... 24.111 Office Visit
.... 24.112 Xylazine drug urine screening tests
.... 24.113 CodeSystem - CDC 2022 Opioid Indicator
.... 24.114 CDC Opioid Override Reasons
.... 24.115 OpioidCDS CarePlan
.... 24.116 Cancer Diagnosis Condition
.... 24.117 End of Life Condition
.... 24.118 Terminal Condition
.... 24.119 Cancer Diagnosis Encounter
.... 24.120 Oncology Participant Encounter
.... 24.121 Ambulatory Opioid MedicationDispense
.... 24.122 OpioidCDS MedicationRequest
.... 24.123 Ambulatory Opioid MedicationRequest
.... 24.124 OpioidCDS Observation
.... 24.125 OpioidCDS Patient
.... 24.126 Oncology Specialist PractitionerRole
.... 24.127 OpioidCDS RequestGroup
.... 24.128 Palliative Care ServiceRequest
.... 24.129 CQFToolingDevice